Yash Suri

Abstracts

1. Suri Y, Nandagopal L, Basu A. Inadequacies in Genetic Testing Referrals and Counseling in Prostate Cancer. Journal of Clinical Oncology; 2020;38(29): DOI: 10.1200/JCO.2020.38.29_suppl.43
2. Basu A, Suri Y, Nandagopal N, Deshazo M. 30 NLR (neutrophil lymphocyte ratio) and PLR (platelet lymphocyte ratio) changes as a predictor of eventual treatment failure and death on nivolumab therapy in renal cell carcinoma; Journal for ImmunoTherapy of Cancer; 2020;8:doi: 10.1136/jitc-2020-SITC2020.0030
3. Basu A, Phone A, Bice T, Sweeney P, Acharya L, Suri Y, Chan A, Nandagopal L, Garje R, Zakharia Y, Kilari Y, Koshkin V, De Shazo M, Barata P, Desai A. Change in neutrophil to lymphocyte ratio (NLR) as a predictor of treatment failure in renal cell carcinoma patients: Analysis of the IROC (Investigating RCC Outcomes) cohort. Journal of Clinical Oncology; 2021; 39(6): DOI: 10.1200/JCO.2021.39.6_suppl.344
4. Suri Y, Latt D; Use of Pro in Evaluating TAA and its Indications; Foot & Ankle Orthopaedics; 2022;7(4): doi.org/10.1177/2473011421S00960
   
    

Manuscripts

 

1. Suri Y. Exploring the Clinical Responses in Glioblastoma Patients From Varying Temozolomide Cycles. Bachelor's thesis, Arizona State University. June 2018:1-62. https://hdl.handle.net/2286/R.I.48028
2. Ojinnaka CO, Suri Y. Impact of Medicaid Expansion on Healthcare Access Among Individuals Living With Chronic Diseases. Am J Prev Med. 2020 Aug;59(2):149-156. doi: 10.1016/j.amepre.2020.03.012.
3. Martin MP, McEntee ML, Suri Y. Caregiver Quality of Life: How to Measure It and Why. Am J Health Promot. 2021 Sep;35(7):1042-1045. doi: 10.1177/08901171211030142f. PMID: 34351244.
4. Johnson SS, Sowa M, McCann R, Cohen SA, Nash CC, Greaney ML, Alexander RA, Kasten J, Martin MP, McEntee ML, Suri Y, Roman C, Bane S, Opthof E. Knowing Well, Being Well: well-being born of understanding: The Science of Teamwork. Am J Health Promot. 2021 Sep;35(7):1028-1047. doi: 10.1177/08901171211030142.
5. Martin MP, Banks E, Myerholtz L, Zubatsky M, Suri Y, Mauksch L. Preparing residents to practice integrated behavioral health care: Multi-site feasibility study of a competency-based curriculum. Int J Psychiatry Med. 2022 Apr 11:912174221086930. doi: 10.1177/00912174221086930.
6. Martin MP, McEntee ML, Mullin D, Suri Y, van Eeghen C. Patient screening for integrated behavioral health in adult primary care: A rapid review of effective procedures. Fam Syst Health. 2022 Sep;40(3):383-396. doi: 10.1037/fsh0000700. 
7. Suri Y, Yasmeh JP, Basu A. Understanding the Uptake and Challenges of Genetic Testing Guidelines for Prostate Cancer Patients. Cancer Treat Res Commun. 2022;32:100588. doi: 10.1016/j.ctarc.2022.100588. 
8. Gbolahan O, Hashemi-Sadraei N, Yash S, Williams G, Ramachandran R, Kim YI, Paluri R, Outlaw D, El-Rayes B, Nabell L. Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer. Cancer Med. 2022 Aug 17. doi: 10.1002/cam4.5133. 
9. Martin M, Suri Y, Doebbeling B, Andrew R, Kathol R. Value-Based Integrated Case Management at Payor Level: Implementation and Impact. Prof Case Manag. 2022 Jan-Feb 01;28(1):11-19. doi: 10.1097/NCM.0000000000000572. PMID: 36394856.
10. Khalpey Z, Wilson P, Suri Y, Culbert H, Deckwa J, Khalpey A, Rozell B. Leveling Up: A Review of Machine Learning Models in The Cardiac ICU. Am J Med. 2023 Jun 19:S0002-9343(23)00389-3. doi: 10.1016/j.amjmed.2023.05.015. PMID: 37343909.
11. Sweeney P, Suri Y, Basu A, Koshkin, V, Desai A. Mechanisms of Tyrosine Kinase Inhibitor Resistance in Renal Cell Carcinoma. Cancer Drug Resistance. 2023 Dec 28. doi: 10.20517/cdr.2023.89
12. Kim, M.,  Suri, Y., Rajendran, I.,  Pineda, JR. The Utility of Sodium-glucose Cotransporter-2 Inhibitors in Treating Myocarditis. The American Journal of Medicine. 2024 Feb. doi:10.1016/j.amjmed.2023.10.005.